Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.38 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.38 |
| ▸ | PELI1 | Q96FA3 | 1/20 | 0.36 |
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.36 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.35 |
| ▸ | TUBB | P07437 | 1/20 | 0.35 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.35 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.35 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.35 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.35 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.35 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.35 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL374848 | 1.00 | NFE2L2 (0.39) | NFE2L2TRPA1LMNAPPARGCYP1A1 | |
| SCHEMBL334592 | 0.98 | NFE2L2 (0.40) | NFE2L2TRPA1LMNAPPARGCYP1A1 | |
| SCHEMBL334593 | 0.98 | NFE2L2 (0.40) | NFE2L2TRPA1LMNAPPARGCYP1A1 | |
| SCHEMBL29617519 | 0.98 | NFE2L2 (0.40) | NFE2L2TRPA1LMNAPPARGCYP1A1 | |
| Ether SCHEMBL2090104 | 0.91 | CHAT (0.36) | NFE2L2TRPA1PPARGCYP1A1CYP1A2 | |
| Ether SCHEMBL2161041 | 0.89 | CHAT (0.37) | NFE2L2TRPA1LMNAPPARGCYP1A1 | |
| Ammonia Solution, Strong SCHEMBL2482264 | 0.88 | NFE2L2 (0.46) | NFE2L2TRPA1LMNAPPARGCISD1 | |
| Sulfuric Acid SCHEMBL2090106 | 0.86 | NFE2L2 (0.40) | NFE2L2TRPA1LMNAPPARGCYP1A1 | |
| SCHEMBL2231182 | 0.86 | NFE2L2 (0.47) | NFE2L2TRPA1LMNAPPARGCISD1 | |
| SCHEMBL30579740 | 0.86 | NFE2L2 (0.47) | NFE2L2TRPA1LMNAPPARGCISD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2129223-B1 | FUNGICIDAL COMPOSITIONS COMPRISING A CARBOXAMIDE DERIVATIVE, CYPRODINIL AND AN UNSATURATED FATTY ACID | SYNGENTA PARTICIPATIONS AG (CH) | 2016-12-14 | — | — | EP | disclosed |
| US-20130178491-A1 | FUNGICIDAL COMPOSITION | SYNGENTA CROP PROTECTION, LLC (US) | 2013-07-11 | — | — | US | disclosed |
| US-20100113552-A1 | FUNGICIDAL COMPOSITION | SYNGENTA CROP PROTECTION, INC. (US) | 2010-05-06 | — | — | US | disclosed |
| EP-2129223-A2 | FUNGICIDAL COMPOSITIONS COMPRISING A CARBOXAMIDE DERIVATIVE, CYPRODINIL AND AN UNSATURATED FATTY ACID | Syngeta Participations AG (CH) | 2009-12-09 | — | — | EP | disclosed |
| WO-2008119439-A2 | FUNGICIDAL COMPOSITIONS COMPRISING A CARBOXAMIDE DERIVATIVE, CYPRODINIL AND AN UNSATURATED FATTY ACID | SYNGENTA PARTICIPATIONS AG (CH) | 2008-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113552-A1 | FUNGICIDAL COMPOSITION | CYCS, CYP1A2, CYP1A1 | NFE2L2 820/4885TRPA1 3090/4885LMNA 1772/4885 |
| US-20130178491-A1 | FUNGICIDAL COMPOSITION | CYP1A2, CYCS, FFAR3 | NFE2L2 826/4885TRPA1 2903/4885LMNA 1714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.